- Oops!Something went wrong.Please try again later.
On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
Earnings and Revenue
Analysts expect Amphastar Pharmaceuticals earnings of $0.14 per share. Revenue will likely be around $86.62 million, according to the consensus estimate. In the same quarter last year, Amphastar Pharmaceuticals reported EPS of $0.080 on revenue of $79.05 million. If the company were to match the consensus estimate, earnings would be up 75.0%. Amphastar Pharmaceuticals's reported EPS has stacked up against analyst estimates in the past like this:
Over the last 52-week period, shares are down 1.19%. Given that these returns are generally negative, long-term shareholders are probably down going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Amphastar Pharmaceuticals is scheduled to hold the call at 17:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/h94bi5cq
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.